论文部分内容阅读
目前,据报导使用抗HBs人免疫球蛋白(HBIG)处理医院内HBV污染事故是有效的。但有关其预防效果在流行病学方面尚未见报告。本院自1975年4月起,每年都对有关人员进行了HBs抗原抗体的定期检测,从1978年8月开始,使用HBIG进行预防,即以HBIG作为预防HBV医院内感染对策的重要一环,给有关人员注射了HBIG。观察对象都系本院职工,初次检测时其HBs抗原抗体均为阴性,其中接受二次以上检查的医师387人,护士912人,临床技师161人,其他工勤人员243人。
Currently, it has been reported that the use of anti-HBs human immunoglobulin (HBIG) to treat hospital-acquired HBV contamination is effective. However, there is no epidemiological report on its preventive effect. Since April 1975, our hospital regularly conducts regular HBs antigen-antibody tests on relevant personnel. Since August 1978, HBIG has been used to prevent HBIG as an important part of the prevention of HBV infection in hospitals. Inject HBIG to the person concerned. All the observers were workers of our hospital. HBs antigen and antibody were all negative when they were tested for the first time. Among them, 387 doctors, 912 nurses, 161 clinical technicians and 243 other workers attended the examination.